Ambient noise levels in the chemotherapy clinic

Dana K. Gladd, Gabrielle Saunders

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Many of the drugs used for chemotherapy treatments are known to be ototoxic, and can result in permanent hearing threshold shifts. The degree of ototoxic damage can be influenced by many factors including dosage, duration of exposure, genetics, and coadministration with other ototoxic agents. Cisplatin is known for its ototoxic effects on hearing thresholds, particularly in the high frequencies. Recent studies have indicated a synergistic relationship between Cisplatin administration and moderate to high noise level exposure starting between 70-85 dB SPL. This study measured the noise levels in the Portland Veteran′s Affairs Medical Center′s outpatient chemotherapy clinic. Average (LAeq) and peak (LCpeak) noise measures were recorded every minute from 7 am until 6 pm on the two busiest clinic days. Patients, visitors, and staff members filled out anonymous surveys regarding their reactions to noise levels. Cumulative noise levels were not at levels known to interact with Cisplatin for a significant period of time. Noise measurement analysis indicated that levels were at or above 70 dB SPL for less than ten minutes during the 11-hour recording window. The patient and visitor surveys indicated that both groups were unbothered by noise in the clinic. However, most staff members were bothered by or concerned about noise levels, and many felt that it caused stress and difficulty communicating on the phone.

Original languageEnglish (US)
Pages (from-to)444-451
Number of pages8
JournalNoise and Health
Volume13
Issue number55
DOIs
StatePublished - Nov 2011

Fingerprint

Noise
Drug Therapy
Visitors to Patients
Cisplatin
Hearing
Veterans
Ambulatory Care Facilities
Pharmaceutical Preparations

Keywords

  • Chemotherapy
  • Cisplatin
  • Noise
  • Noise disturbance

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Public Health, Environmental and Occupational Health
  • Speech and Hearing

Cite this

Ambient noise levels in the chemotherapy clinic. / Gladd, Dana K.; Saunders, Gabrielle.

In: Noise and Health, Vol. 13, No. 55, 11.2011, p. 444-451.

Research output: Contribution to journalArticle

Gladd, Dana K. ; Saunders, Gabrielle. / Ambient noise levels in the chemotherapy clinic. In: Noise and Health. 2011 ; Vol. 13, No. 55. pp. 444-451.
@article{ca4b66a0dbc744fbab7c02aa236fce12,
title = "Ambient noise levels in the chemotherapy clinic",
abstract = "Many of the drugs used for chemotherapy treatments are known to be ototoxic, and can result in permanent hearing threshold shifts. The degree of ototoxic damage can be influenced by many factors including dosage, duration of exposure, genetics, and coadministration with other ototoxic agents. Cisplatin is known for its ototoxic effects on hearing thresholds, particularly in the high frequencies. Recent studies have indicated a synergistic relationship between Cisplatin administration and moderate to high noise level exposure starting between 70-85 dB SPL. This study measured the noise levels in the Portland Veteran′s Affairs Medical Center′s outpatient chemotherapy clinic. Average (LAeq) and peak (LCpeak) noise measures were recorded every minute from 7 am until 6 pm on the two busiest clinic days. Patients, visitors, and staff members filled out anonymous surveys regarding their reactions to noise levels. Cumulative noise levels were not at levels known to interact with Cisplatin for a significant period of time. Noise measurement analysis indicated that levels were at or above 70 dB SPL for less than ten minutes during the 11-hour recording window. The patient and visitor surveys indicated that both groups were unbothered by noise in the clinic. However, most staff members were bothered by or concerned about noise levels, and many felt that it caused stress and difficulty communicating on the phone.",
keywords = "Chemotherapy, Cisplatin, Noise, Noise disturbance",
author = "Gladd, {Dana K.} and Gabrielle Saunders",
year = "2011",
month = "11",
doi = "10.4103/1463-1741.90322",
language = "English (US)",
volume = "13",
pages = "444--451",
journal = "Noise and Health",
issn = "1463-1741",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "55",

}

TY - JOUR

T1 - Ambient noise levels in the chemotherapy clinic

AU - Gladd, Dana K.

AU - Saunders, Gabrielle

PY - 2011/11

Y1 - 2011/11

N2 - Many of the drugs used for chemotherapy treatments are known to be ototoxic, and can result in permanent hearing threshold shifts. The degree of ototoxic damage can be influenced by many factors including dosage, duration of exposure, genetics, and coadministration with other ototoxic agents. Cisplatin is known for its ototoxic effects on hearing thresholds, particularly in the high frequencies. Recent studies have indicated a synergistic relationship between Cisplatin administration and moderate to high noise level exposure starting between 70-85 dB SPL. This study measured the noise levels in the Portland Veteran′s Affairs Medical Center′s outpatient chemotherapy clinic. Average (LAeq) and peak (LCpeak) noise measures were recorded every minute from 7 am until 6 pm on the two busiest clinic days. Patients, visitors, and staff members filled out anonymous surveys regarding their reactions to noise levels. Cumulative noise levels were not at levels known to interact with Cisplatin for a significant period of time. Noise measurement analysis indicated that levels were at or above 70 dB SPL for less than ten minutes during the 11-hour recording window. The patient and visitor surveys indicated that both groups were unbothered by noise in the clinic. However, most staff members were bothered by or concerned about noise levels, and many felt that it caused stress and difficulty communicating on the phone.

AB - Many of the drugs used for chemotherapy treatments are known to be ototoxic, and can result in permanent hearing threshold shifts. The degree of ototoxic damage can be influenced by many factors including dosage, duration of exposure, genetics, and coadministration with other ototoxic agents. Cisplatin is known for its ototoxic effects on hearing thresholds, particularly in the high frequencies. Recent studies have indicated a synergistic relationship between Cisplatin administration and moderate to high noise level exposure starting between 70-85 dB SPL. This study measured the noise levels in the Portland Veteran′s Affairs Medical Center′s outpatient chemotherapy clinic. Average (LAeq) and peak (LCpeak) noise measures were recorded every minute from 7 am until 6 pm on the two busiest clinic days. Patients, visitors, and staff members filled out anonymous surveys regarding their reactions to noise levels. Cumulative noise levels were not at levels known to interact with Cisplatin for a significant period of time. Noise measurement analysis indicated that levels were at or above 70 dB SPL for less than ten minutes during the 11-hour recording window. The patient and visitor surveys indicated that both groups were unbothered by noise in the clinic. However, most staff members were bothered by or concerned about noise levels, and many felt that it caused stress and difficulty communicating on the phone.

KW - Chemotherapy

KW - Cisplatin

KW - Noise

KW - Noise disturbance

UR - http://www.scopus.com/inward/record.url?scp=82955175515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955175515&partnerID=8YFLogxK

U2 - 10.4103/1463-1741.90322

DO - 10.4103/1463-1741.90322

M3 - Article

VL - 13

SP - 444

EP - 451

JO - Noise and Health

JF - Noise and Health

SN - 1463-1741

IS - 55

ER -